<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: TNF-alpha caused <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> on <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake and on insulin signalling in fetal brown adipocytes </plain></SENT>
<SENT sid="1" pm="."><plain>Since treatment with TNF-alpha activates stress kinases, including c-jun <z:chebi fb="0" ids="29318,29339">NH2</z:chebi> terminal kinase (JNK), and p42/p44 and p38 <z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein kinases (MAPK), we explored the contribution of these pathways to <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> by TNF-alpha </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="50122">Rosiglitazone</z:chebi> is used to treat Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> as it improves insulin sensitivity in vivo </plain></SENT>
<SENT sid="3" pm="."><plain>However, its ability to ameliorate TNF-alpha-induced <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in brown adipocytes remains to be explored </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: We used fetal rat primary brown adipocytes cultured with TNF-alpha, with or without stress kinase inhibitors or <z:chebi fb="0" ids="50122">rosiglitazone</z:chebi>, and further stimulated with insulin </plain></SENT>
<SENT sid="5" pm="."><plain>Then, we measured <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake and GLUT4 translocation </plain></SENT>
<SENT sid="6" pm="."><plain>To determine the insulin signalling cascade, we submitted cells to lysis, immunoprecipitation and immunoblotting </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Exposure to TNF-alpha for 24 h impairs insulin stimulation of the phosphatidylinositol (PI) 3-kinase activity associated with IRS-2 and Akt activity </plain></SENT>
<SENT sid="8" pm="."><plain>Pretreatment with PD98059 or PD169316, which inhibit p42/p44MAPK and p38MAPK respectively, restored insulin signalling and insulin-induced <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake in the presence of TNF-alpha </plain></SENT>
<SENT sid="9" pm="."><plain>However, in the presence of SP600125, an inhibitor of JNK, TNF-alpha still produced <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="0" ids="50122">Rosiglitazone</z:chebi> ameliorated <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> by TNF-alpha in brown adipocytes, restoring completely insulin-stimulated <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake and insulin-induced GLUT4 translocation to plasma membrane in parallel to the insulin signalling cascade IRS-2/PI 3-kinase/Akt </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS/INTERPRETATION: <z:chebi fb="0" ids="50122">Rosiglitazone</z:chebi> treatment impaired TNF-alpha activation of p38 and p42/p44MAPK, restoring insulin signalling and leading to normalisation of <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake </plain></SENT>
</text></document>